Arrest of Progression of Pre-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice by Low Level Laser Phototherapy

被引:6
|
作者
Gavish, Lilach [1 ]
Beeri, Ronen [2 ]
Gilon, Dan [2 ]
Rubinstein, Chen [3 ]
Berlatzky, Yacov [3 ]
Bulut, Atilla [2 ]
Reissman, Petachia [4 ]
Gavish, Leah Y. [1 ]
Gertz, S. David [1 ]
机构
[1] Hebrew Univ Jerusalem, IMRIC, Inst Med Res, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Cardiol, IL-91120 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Vasc Surg, IL-91120 Jerusalem, Israel
[4] Shaarei Zedek Hosp, Dept Surg, Jerusalem, Israel
基金
以色列科学基金会;
关键词
aneurysm; abdominal aortic aneurysm; angiotensin-II; low level laser (light) therapy (LLLT); apolipoprotein-E-deficient mice; photobiomodulation (PBM); SMOOTH-MUSCLE-CELLS; VASCULAR-SURGERY; ORAL MUCOSITIS; DIODE-LASER; ATHEROSCLEROSIS; IRRADIATION; THERAPY; PATHOGENESIS; EXPRESSION; MANAGEMENT;
D O I
10.1002/lsm.22306
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and ObjectivesUsing non-invasive, high-frequency ultrasonography (HF-u/s), we showed that low-level laser phototherapy (LLL) inhibits de-novo formation of abdominal aortic aneurysms (AAA) in apolipoprotein-E-deficient (Apo-E-/-) mice. The current study tests the effect of LLL on the progression of pre-induced AAA. Study Design/Material and MethodsAAA was induced in Apo-E-/- mice (age16-20 weeks) by subcutaneous infusion of angiotensin-II using osmotic minipumps (1000ng/kg/minutes, 4 weeks). HF-u/s (40MHz, 0.01mm resolution, Vevo-770, VisualSonics) was used to measure the maximum cross-sectional-diameter (MCD) of the suprarenal abdominal aorta, the anterior wall displacement (AWD), and radial wall velocity (RWV). The aortas of mice that developed >35% dilatation at 2 weeks over baseline were exposed retroperitoneally and treated with LLL (780nm, 2.2J/cm(2), 9minutes) or sham-operated. HF-u/s was repeated at 4 weeks, the mice sacrificed by perfusion fixation, and the aortas excised for histopathology. ResultsOf all mice with >35% MCD expansion of the suprarenal aorta at 2 weeks, 7(58%) of 12 non-treated, but only 1(7%) of 14 LLL, had increased MCD(>1SD) at 4weeks (P<0.009 by Fisher's Exact Test [FET]). The mean change in MCD from 2-4weeks was also markedly reduced in the LLL-treated mice (control vs. LLL, 0.240.25 vs. -0.06 +/- 0.39mm, P=0.029 by unpaired t-test). Similar results were obtained when limiting the analysis to animals with 50% expansion at 2 weeks. The deterioration in AWD from 2-4 weeks in non-treated controls was not observed in LLL-treated animals (AWD: control, 0.03 +/- 0.05mm, P<0.036 vs. LLL, 0.00 +/- 0.05, P=0.91 by paired t-test). By the modified Daugherty classification, we found significantly fewer severe aneurysms at 4 weeks in the LLL-treated animals versus control (3 of 10 vs. 9 of 11, P=0.03 by FET). ConclusionsLLL not only prevents de novo development of AAA, but, from this study, also arrests further progression of pre-induced AAA and its associated deterioration in the biomechanical integrity of the aortic wall in Apo-E-/- mice. Lasers Surg. Med. 46:781-790, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:781 / 790
页数:10
相关论文
共 50 条
  • [11] Osteopontin N-Terminal Function in an Abdominal Aortic Aneurysm From Apolipoprotein E-Deficient Mice
    Liu, Hongyang
    Zhang, Ying
    Song, Wei
    Sun, Yancui
    Jiang, Yinong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [12] Osteopontin N-Terminal Function in an Abdominal Aortic Aneurysm From Apolipoprotein E-Deficient Mice
    Liu, Hongyang
    Zhang, Ying
    Song, Wei
    Sun, Yancui
    Jiang, Yinong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [13] Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
    Qin, Yanwen
    Cao, Xu
    Guo, Jun
    Zhang, Yaozhong
    Pan, Lili
    Zhang, Hongjia
    Li, Huihua
    Tang, Chaoshu
    Du, Jie
    Shi, Guo-Ping
    CARDIOVASCULAR RESEARCH, 2012, 96 (03) : 401 - 410
  • [14] Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused, apolipoprotein E-deficient mice
    McCormick, ML
    Gavrila, D
    Daugherty, A
    Cassis, LA
    Miller, FJ
    Oberley, LW
    Dellsperger, KC
    Weintraub, NL
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S137 - S137
  • [15] Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice
    Gavrila, D
    Li, WG
    McCormick, ML
    Thomas, M
    Daugherty, A
    Cassis, LA
    Miller, FJ
    Oberley, LW
    Dellsperger, KC
    Weintraub, NL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 1671 - 1677
  • [16] Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused, apolipoprotein E-deficient mice.
    Gavrila, D
    Li, WG
    Daugherty, A
    Cassis, LA
    Miller, FJ
    Oberley, LW
    Dellsperger, KC
    Weintraub, NL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (02) : S357 - S358
  • [17] Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice
    Cao, Richard Yang
    Adams, Michael A.
    Habenicht, Andreas J.
    Funk, Colin D.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 84 (1-2) : 34 - 42
  • [18] Recombinant leptin attenuates abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice
    Zhang, Ying
    Yuan, Haitao
    Bu, Peili
    Shen, Ying H.
    Liu, Tongbao
    Song, Shangming
    Hou, Xiaoyang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1450 - 1456
  • [19] Enkephalin receptor activation attenuates abdominal aortic aneurysm formation in angiotensin II infused apolipoprotein e-deficient mice
    Blomkalns, A. L.
    Ormond, S. M.
    Stoll, L. L.
    Denning, G. M.
    Dickson, E. W.
    Weintraub, N. L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 624 - 624
  • [20] Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice
    Stolle, Katrin
    Berges, An
    Lietz, Michael
    Lebrun, Stefan
    Wallerath, Thomas
    TOXICOLOGY LETTERS, 2010, 199 (03) : 403 - 409